Supervisory Board Member

Dr. Barbara Gansewendt*

Barbara Gansewendt

Member of the Supervisory Board effective April 2022, elected until 2027

Chairwoman of the Bayer Group Executives´ Committee

Chairwoman of the Executives´ Committee of Bayer AG, Wuppertal

 

 

*employee representative

 

Curriculum Vitae

September 29, 1963 born in Bocholt, grown up in Dortmund, Germany
1982–1987 Pharmacy studies at University of Muenster with mandatory pharmacy internship in Göttingen
1987 State Accreditation as Pharmacist
1988–1992 Toxicology Research associate / Postdoctoral Research Fellow in toxicology at IfADo – Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany
1990 PhD Graduation: Doctorate in pharmaceutical chemistry granted from University of Muenster
1992 Registered Toxicologist (DGPT and EuroTox)
1992 Joined Bayer AG and held different positions in Drug Regulatory Affairs since then
1992–1999 Regulatory Affairs Project Leader (Bayer Vital GmbH & Co KG, Leverkusen)
2000–2002 Global Regulatory Affairs Manager (Bayer Pharma AG, Wuppertal)
2002–2004 European RA Strategy Leader (Bayer Healthcare AG, Wuppertal)
2004–2010 Head of Regulatory Affairs Germany, Pharma (Bayer Vital GmbH, Leverkusen)
since 2010 VP, Global Head of Regulatory Submission Management (Bayer AG, Wuppertal)
2006–2019 Board Member (Treasurer) of the German Society of Drug Regulatory Affairs (DGRA), Bonn
since 1992 Member of the Association of Academic Employees (VAA), today deputy chair of the VAA – Group Elberfeld
since 2014 Member of the Executives´ Committee Bayer AG Wuppertal
since 2015 Chairwoman of the Executives´ Committee Bayer AG Wuppertal und Member of the Bayer Group Executives´ Committee
2018–2022 Vice Chairwoman of the Bayer Group Executives‘ Committee
since 2022 Chairwoman of the Bayer Group Executives‘ Committee